Gel treatment for diabetic foot ulcers study
Part of Heart & circulation, Hormones & metabolism, Skin clinical trials.
This trial tests a new gel (MDI-1228-mesylate) applied to diabetic foot ulcers to see if it helps them heal faster than standard care alone. It is for people who have had a foot ulcer for at least 12 weeks and are already receiving standard treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 75 years old
- Have diabetes and at least one foot ulcer on the top, bottom, or below the knee
- The ulcer must be Wagner grade 2 (moderate depth, no infection throughout the body)
- The ulcer must have been present for at least 12 weeks and treated with standard care for the last 4 weeks
- The ulcer should be no larger than 25 square centimeters, and there must be at least 3 centimeters between it and any other ulcer on the same foot
- You cannot be allergic to the study gel or similar medications like tofacitinib
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial tests ENERGI-F703 gel to help heal diabetic foot ulcers that have not improved for at least 4 weeks. It may help some people whose wounds meet specific size and non-infection criteria.
This study tests a new wound therapy for diabetic foot ulcers that haven't healed with standard care. It aims to see if the therapy helps these ulcers heal better and faster.
This trial tests whether adding a special treatment (cellular acellular and matrix-like products) to standard wound care helps diabetic foot ulcers and venous leg ulcers heal faster. It may be an option if you have a diabetes-related foot ulcer that hasn't healed with standard care.
This trial tests a new wound covering called NeoThelium FT to help diabetic foot ulcers heal. It is for people whose ulcer has not improved much with standard care and is not infected or too deep.
This study tests if a special wound dressing (collagen matrix with antimicrobial) plus standard care helps diabetic foot ulcers heal better than standard care alone. It's for people with diabetes who have a foot sore that hasn't healed for at least 4 weeks.
This trial tests a new cell treatment for diabetic foot ulcers by injecting special regulatory monocytes (OPM cells) to help heal wounds. It is for patients with mild to moderate ulcers that haven't healed for over a month.
Hear when a new Diabetic Foot Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.